Skip to main content
Article
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
Liver Transplantation (2011)
  • Göran B. Klintmalm, Baylor University Medical Center
  • Gary L. Davis, Baylor University Medical Center
  • Lewis Teperman, New York University
  • George J. Netto, Johns Hopkins University
  • Kenneth Washburn, University of Texas Health Science Center at San Antonio
  • Stephen M. Rudich, University of Cincinnati
  • Elizabeth A. Pomfret, Lahey Hospital & Medical Center
  • Hugo E. Vargas, Mayo Clinic
  • Robert Brown, NewYork–Presbyterian Hospital
  • Devin Eckhoff, University of Alabama at Birmingham
  • Timothy L. Pruett, University of Virginia
  • John Roberts, University of California, San Francisco
  • David C. Mulligan, Mayo Clinic
  • Michael R. Charlton, Mayo Clinic
  • Thomas G. Heffron, Emory University
  • John M. Ham, Oregon Health & Science University
  • David D. Douglas, Mayo Clinic
  • Linda Sher, University of Southern California
  • Prabhakar K. Baliga, Medical University of South Carolina
  • Milan Kinkhabwala, NewYork–Presbyterian Hospital
  • Baburao Koneru, University of Medicine and Dentistry of New Jersey
  • Michael Abecassis, Northwestern University
  • Michael Millis, University of Chicago
  • Linda W. Jennings, Baylor University Medical Center
  • Carlos G. Fasola, Emory University
  • Carlos G. Fasola, Scott & White Hospital
Publication Date
December 1, 2011
DOI
10.1002/LT.22417
Citation Information
Göran B. Klintmalm, Gary L. Davis, Lewis Teperman, George J. Netto, et al.. "A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C." Liver Transplantation Vol. 17 Iss. 12 (2011) p. 1394 - 1403
Available at: http://works.bepress.com/thomas-heffron/4/